Per Stenqvist

Per Stenqvist is an accomplished professional in the pharmaceutical industry with extensive experience in portfolio management and business development. Currently serving as Director Pipeline Portfolio at Recipharm since May 2018, Per previously held the position of Head of Business Development at RPH Pharmaceuticals. Earlier roles include Senior Portfolio Manager at Teva Pharmaceuticals for Denmark, Norway, and Iceland, and Portfolio Manager for the Nordics at Allergan, focusing on market analysis and drug evaluation across multiple therapeutic areas. Per's career also encompasses managerial positions at Actavis (now Allergan) and Meda, alongside experience as a Training Manager and Pharmacy Manager at DocMorris Apotek Sverige. Per's educational background includes a Master of Science in Pharmacy from Uppsala University, complemented by a PhD in Toxicology obtained during a prior academic tenure at the same institution.